Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johanna Himelreichs

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Revista Medica De Chile|May 27, 2024
[Assessing Convalescent Plasma Efficacy in Moderate COVID-19 Hospitalizations: A Bicentric Retrospective Study]Vivianne Torres, Felipe Olivares, Catherine Fernández, et al.
International Journal of Molecular Sciences|October 16, 2025
Novel Type IIS-Based Library Assembly Technique for Developing Nanobodies Targeting IPNv VP2 ProteinCamila Pino-Belmar, Johanna Himelreichs, Camila Deride, et al.
Scientific Reports|February 9, 2021
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobodyGuillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, et al.
Nature Structural & Molecular Biology|July 8, 2025
A nanobody-based therapeutic targeting Nipah virus limits viral escapeAriel Isaacs, Guillermo Valenzuela Nieto, Xinghai Zhang, et al.
Iscience|June 26, 2023
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Revista Medica De Chile|May 27, 2024
[Assessing Convalescent Plasma Efficacy in Moderate COVID-19 Hospitalizations: A Bicentric Retrospective Study]Vivianne Torres, Felipe Olivares, Catherine Fernández, et al.
International Journal of Molecular Sciences|October 16, 2025
Novel Type IIS-Based Library Assembly Technique for Developing Nanobodies Targeting IPNv VP2 ProteinCamila Pino-Belmar, Johanna Himelreichs, Camila Deride, et al.
Scientific Reports|February 9, 2021
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobodyGuillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, et al.
Nature Structural & Molecular Biology|July 8, 2025
A nanobody-based therapeutic targeting Nipah virus limits viral escapeAriel Isaacs, Guillermo Valenzuela Nieto, Xinghai Zhang, et al.
Iscience|June 26, 2023
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.
Pageof 1